Evidence map›Paper›PMID 19152337›Full record

ArticleEuropean journal of immunology2009

Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7.

Delphine Goubau, Raphaëlle Romieu-Mourez, Mayra Solis, Eduardo Hernandez, Thibault Mesplède, Rongtuan Lin, Douglas Leaman, John Hiscott

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. CombinedInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Article
  5. When ASFV Infection Meets the cGAS-STING Signaling Pathway.Transboundary and emerging diseases · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Antigen Cross-Presentation by Macrophages.Frontiers in immunology · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Delphine GoubauTerry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, McGill University, Montreal, Que, Canada.
Raphaëlle Romieu-Mourez
Mayra Solis
Eduardo Hernandez
Thibault Mesplède
Rongtuan Lin
Douglas Leaman
John Hiscott
McGill University · CATerry Fox Research Institute · CAJewish General Hospital · CAUniversity of Toledo · US

Funding

Impact of the interferon regulated proteins XAF1 and ZNF313 on innate immunityR01AI068133 · NIAID · UNIVERSITY OF TOLEDO · PI LEAMAN, DOUGLAS W · 2006 to 2010
$1.2M
NIAID NIH HHS R01 AI068133
6 · The paper itself

Abstract

The immunoregulatory transcriptional modulators - IFN-regulatory factor (IRF)-3 and IRF-7 - possess similar structural features but distinct gene-regulatory potentials. For example, adenovirus-mediated transduction of the constitutively active form of IRF-3 triggered cell death in primary human MPhi, whereas expression of active IRF-7 induced a strong anti-tumoral activity in vitro. To further characterize target genes involved in these distinct cellular responses, transcriptional profiles of active IRF-3- or IRF-7-transduced primary human MPhi were compared and used to direct further mechanistic studies. The pro-apoptotic BH3-only protein Noxa was identified as a primary IRF-3 target gene and an essential regulator of IRF-3, dsRNA and vesicular stomatitis virus-induced cell death. The critical role of IRF-7 and type I IFN production in increasing the immunostimulatory capacity of MPhi was also evaluated; IRF-7 increased the expression of a broad range of IFN-stimulated genes including immunomodulatory cytokines and genes involved in antigen processing and presentation. Furthermore, active IRF-7 augmented the cross-presentation capacity and tumoricidal activity of MPhi and led to an anti-tumor response against the B16 melanoma model in vivo. Altogether, these data further highlight the respective functions of IRF-3 and IRF-7 to program apoptotic, immune and anti-tumor responses.

Indexed as

AnimalsApoptosisCell LineCell Line, TumorCells, CulturedFemaleGene Expression ProfilingGene Knockout TechniquesHumansInterferon Regulatory Factor-3Interferon Regulatory Factor-7MacrophagesMiceNeoplasmsProto-Oncogene Proteins c-bcl-2Transcription, GeneticInterferon Regulatory Factor-3Interferon Regulatory Factor-7PMAIP1 protein, humanProto-Oncogene Proteins c-bcl-2

Identifiers

PMID19152337
PMCPMC2773157
OpenAlexW1999792663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.